Oncology Pharma Inc. (ONPH)
USD 0.0
(100.0%)
USD 0.0
(100.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2004 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | 368.6 Thousand | -117.07 Thousand | -22.41 Thousand | -36.9 Thousand | -2 Million |
| Net Income | - | -104.62 Million | -97.47 Million | -207.55 Thousand | -850.39 Thousand | -1.56 Million |
| Depreciation & Amortization | - | - | 779.00 | 1109.00 | 1109.00 | 81 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 357.9 Thousand | 325.69 Thousand | -196.32 Thousand | 35.16 Thousand | -381 Thousand |
| Other non-cash items | - | 104.63 Million | 97.03 Million | 382.57 Thousand | 777.21 Thousand | -135 Thousand |
| Investing Cash Flow | - | -1.78 Million | -321.95 Thousand | - | - | 116 Thousand |
| Investments in PPE | - | - | - | - | - | -17 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -1.78 Million | -321.95 Thousand | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 133 Thousand |
| Financing Cash Flow | - | 1.4 Million | 446.17 Thousand | 17.51 Thousand | 42.88 Thousand | 546 Thousand |
| Debt repayment | - | -6400.00 | -111.92 Thousand | -17.51 Thousand | -42.88 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 1.4 Million | 334.25 Thousand | - | - | 461 Thousand |
| Other Financing Activities | - | - | - | - | 85.77 Thousand | 85 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | 35.16 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | 357.9 Thousand | 325.69 Thousand | -196.32 Thousand | - | - |
| Cash at beginning of period | 3964.00 | 8954.00 | 1805.00 | 6708.00 | 728.00 | 1.34 Million |
| Cash at end of period | 3964.00 | 3964.00 | 8954.00 | 1805.00 | 6708.00 | 8000.00 |
| Capital Expenditure | - | - | - | - | - | -17 Thousand |
| Effect of forex changes on cash | - | 1.00 | - | - | - | - |
| Net cash flow / Change in cash | - | -4990.00 | 7149.00 | -4903.00 | 5980.00 | -1.33 Million |
| Free Cash Flow | - | 368.6 Thousand | -117.07 Thousand | -22.41 Thousand | -36.9 Thousand | -2.01 Million |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | - | - | -254.88 Thousand | -5.31 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | 22.49 Thousand | 100.01 Thousand |
| Other non-cash items | - | - | - | - | 230.4 Thousand | 5.21 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | 600.00 | 4200.00 |
| Debt repayment | - | - | - | - | -600.00 | -4200.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | 8400.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | 22.49 Thousand | 100.01 Thousand |
| Cash at beginning of period | - | - | 398.00 | 3964.00 | 1783.00 | 1183.00 |
| Cash at end of period | - | - | 398.00 | 3964.00 | 398.00 | 1783.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | - | -1385.00 | 600.00 |
| Free Cash Flow | - | - | - | - | -1984.00 | -3600.00 |
S32
002350
300602
ERO
301211
FBU